Polymer nanocomposites (PNCs) are advanced materials combining polymer matrices with nanoscale fillers such as clays, metal nanoparticles, and biocompatible ceramics, resulting in composites with enhanced mechanical, thermal, and functional properties. These materials are transformative in pharmaceutical applications, offering solutions for drug formulation and delivery challenges. PNCs enable precise control over drug release kinetics, improve bioavailability, and allow targeted delivery to specific tissues or cells. Encapsulating active pharmaceutical ingredients (APIs) enhances solubility, stability, and therapeutic efficacy. Drawing from material science, nanotechnology, and biology, PNCs have revolutionized drug delivery systems, prosthetics, and sustained release technologies, bridging traditional polymers with cutting-edge nanotechnology for improved medical outcomes. Polymer nanocomposites have emerged as a transformative innovation in pharmaceutical formulations, providing unprecedented versatility in drug delivery systems. This chapter will explore the design and synthesis of polymer nanocomposites tailored for pharmaceutical applications, emphasizing their physicochemical properties, biocompatibility, and enhanced functionality. Key topics include the role of polymer matrices and various nanofillers (e.g., metal oxides, carbon-based materials, and biocompatible ceramics) in modulating drug release profiles, improving bioavailability, and achieving targeted delivery. Furthermore, the chapter will review advances in surface functionalization and encapsulation strategies that enhance the stability and solubility of active pharmaceutical ingredients (APIs) within polymer nanocomposite matrices. Case studies on applications in chronic disease management, oncology, and infectious disease treatment will illustrate the therapeutic potential of polymer nanocomposites. The discussion will also highlight critical characterization techniques essential for optimizing pharmaceutical nanocomposites, including SEM, TEM, and FTIR. Finally, the chapter will address regulatory considerations, biocompatibility, and safety profiles to ensure effective translation from lab to clinical application. The insights presented in this chapter on polymer nanocomposites (PNCs) aim to bridge gaps in knowledge and practice for diverse stakeholders in the pharmaceutical field. Researchers and formulators will find valuable strategies for developing innovative drug delivery systems, while analysts will gain a deeper understanding of techniques to evaluate and optimize nanocomposite formulations. Policymakers and regulatory professionals can use the discussion on safety and compliance to inform guidelines and frameworks for integrating these materials into mainstream healthcare. By advancing scientific knowledge in material science and nanotechnology, this chapter contributes to the development of safer, more effective pharmaceutical solutions, ultimately improving patient care and inspiring future research.